Sponsored Research
Jonathan Piccini of Cardiology has received an award from the American Heart Association for a project entitled "Get With The Guidelines (GWTG) Task Order #24." Total funding will be $137,739.
Dylan S. Eiger (Mentor: Sudarshan Rajagopal) of Cardiology has received an award from the American Heart Association for a project entitled "CXCR3 in Atherosclerosis." Total funding will be $31,016.
Sreekanth Vemulapalli of Cardiology has received an award from the Society of Thoracic Surgeons for a project entitled "Statistical Support Center for the Adult Cardiac Surgery, Congenital and Thoracic Databases." Total funding will be $4,191,311.
Sreekanth Vemulapalli of Cardiology has received a sub-award (5U01-FD006292-03) through the Weill Medical College of Cornell University for a project entitled "Real World Assessment of Vascular Device Safety and Effectiveness." Total funding will be $95,775.
Farr Curlin of General Internal Medicine has received a sub-award () through the Foundation for Excellence in Education for a project entitled "Arete Initiative Operational Support." Total funding will be $205,000.
Farr Curlin of General Internal Medicine has received a sub-award () through the Foundation for Excellence in Education for a project entitled "Seminars on Faith and Science." Total funding will be $1.
Christopher Bowling of Geriatrics has received an award (1R01-AG062502-01A1) from the National Institutes of Health for a project entitled "Functional Limitations and Disability Among Middle-Aged Adults." Total funding will be $2,202,666.
Kimberly Johnson of Geriatrics has received an award (3U54-MD012530-03S1) from the National Institutes of Health for a project entitled "Racial and Ethnic Disparities in Clinician-Caregiver Communication During Family-Centered Rounds." Total funding will be $237,422.
Dorothy Sipkins of Hematologic Malignancies and Cellular Therapy has received an award (1R01-CA234580-01A1) from the National Institutes of Health for a project entitled "Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis." Total funding will be $1,799,991.
Scott Antonia of Medical Oncology has received an award from the Anonymous Trust for a project entitled "Anonymous Donation." Total funding will be $50,000.
Gentzon Hall of Nephrology has received a sub-award (5P30-DK114857-02) through the Northwestern University for a project entitled "Exploring the Therapeutic Potential of Novel Discoveries in Hereditary Nephrotic Syndrome." Total funding will be $64,999.
Loretta Que of Pulmonary has received a sub-award (1R01-HL146542-01) through the University of Colorado - Denver for a project entitled "A Randomized Phase II Clinical Trial of L-Citrulline to Improve Asthma Control in Obese Late Onset Asthma." Total funding will be $306,089.
Scott Shofer of Pulmonary has received a sub-award (W81XWH1910341) through the Institute for Medical Research, Inc. for a project entitled "PSA for Jessica Shier." Total funding will be $21,732.
Laurie Snyder of Pulmonary has received an award from the Cystic Fibrosis Foundation for a project entitled "Cystic Fibrosis Lung Transplant Consortium." Total funding will be $436,800.
Industry-sponsored Clinical Trials
John Alexander of Cardiology has received an award from XaTek Inc. for a project entitled "ClotChip." Total funding will be $1,987,147.
Gary Felker of Cardiology has received an award from Daxor Corporation for a project entitled "DAXOR - BVA Trial." Total funding will be $128,001.
Adrian Hernandez of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "HFN LIFE Industry Supplemental Funding." Total funding will be $743,103.
Christopher Holley of Cardiology has received an award from CareDx, Inc. for a project entitled "Increasing the Diagnostic Accuracy of Antibody Mediated." Total funding will be $97,895.
Martin Moseley III of Cardiology has received an award from IMMvention Therapeutix for a project entitled "SRA IMMvention Therapeutix, Inc." Total funding will be $4,999.
Manesh Patel of Cardiology has received an award from Volcano Corporation for a project entitled "Radiographic imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)." Total funding will be $58,144.
Danielle Brander of Hematologic Malignancies and Cellular Therapy has received an award from TG Therapeutics, Inc for a project entitled "A Phase 1 study of ublituximab and umbralisib in combination with targeted immunotherapy in patients with relapsed-refractory CLL or Richter's transformation of CLL." Total funding will be $212,941.
Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from ImmunoGen, Inc. for a project entitled "ImmunoGen_0802: Ph 1b/2 IMGN632." Total funding will be $326,312.
Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from PTC Therapeutics, Inc for a project entitled "Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias." Total funding will be $258,910.
Thomas Leblanc of Hematologic Malignancies and Cellular Therapy has received an award from The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership for a project entitled "Real-World Use of Immunotherapy Agents vs. Chemotherapy agents for Metastatic Non-Cell Lung Cancer (mNSCLC): a Retrospective Cohort Study of Patient's Experiences and Associated Outcomes." Total funding will be $396,462.
Matthew McKinney of Hematologic Malignancies and Cellular Therapy has received an award from Novartis Pharmaceuticals Corporation for a project entitled "A multicenter retrospective non-interventional follow-up study in patients with sickle cell pain crisis who previously participated in the SUSTAIN trial in the United States." Total funding will be $423,760.
Matthew McKinney of Hematologic Malignancies and Cellular Therapy has received an award from Unum Therapeutics Inc. for a project entitled "ATTCK-20-03." Total funding will be $385,000.
Matthew McKinney of Hematologic Malignancies and Cellular Therapy has received an award from Atara Biotherapeutics, Inc. for a project entitled "Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disease after Failure of Rituximab or Roituximab and Chemotherapy." Total funding will be $276,126.
Thomas Ortel of Hematology has received an award from Instrumentation Laboratory Company for a project entitled "L000013105 Protocol for Reagent Reproducibility of Liquid Anti-Xa Assay with Apixaban Calibrators on ACL TOP Analyzers." Total funding will be $115,649.
Andrew Armstrong of Medical Oncology has received an award from BeiGene, Ltd for a project entitled "A Phase 2, Open-Label, Single-Arm Study of Pamiparib (BGB-290) for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Homologous Recombination Deficiency (HRD) (Beigene)." Total funding will be $223,310.
Jeremy Force of Medical Oncology has received an award from Array BioPharma Inc for a project entitled "TBCRC 047." Total funding will be $13,698.
Thomas Stinchcombe of Medical Oncology has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "A PHASE 1/2 STUDY OF REGN5093 IN PATIENTS WITH MET-ALTERED ADVANCED NON-SMALL CELL LUNG CANCER." Total funding will be $589,731.
Anne Mathews of Pulmonary has received a sub-award (5U01-HL128954-05) through COPD Foundation Inc for a project entitled "Intervention Study In overweight patients with COPD (INSIGHT COPD) trial." Total funding will be $1.